Abstract
Purpose
To evaluate pH-sensitive mixed micelles for multidrug resistant (MDR) ovarian tumor targeting and optical imaging of solid tumors.
Method
Doxorubicin (DOX) encapsulated pH-sensitive mixed micelles composed of poly(l-histidine)(MW 5K)-b-PEG(MW 2K) and poly(l-lactic acid)(3K)-b-PEG (2K)-folate (PHSM-f) were prepared. Folate receptor-mediated endocytosis, drug uptake, endosomal disruption and cell viability were investigated at the cellular level. For in vivo tumor growth inhibition tests, multidrug resistant ovarian A2780/DOXR xenografted nude mice were used. Optical imaging was performed by using a Cy5.5 fluorescence dye-labeled mixed micelle system. Cy5.5 fluorescence intensity at the tumor site was measured in KB epidermoid xenografted nude mice.
Results
In vitro cell viability and drug distribution in the cytoplasm demonstrated the significantly superior efficacy of PHSM-f to free DOX and a control sample of DOX loaded pH-insensitive micelle composed of poly(l-lactic acid)(3K)-b-PEG(2K)/poly(l-lactic acid)(3K)-b-PEG(2K)-folate (80/20 wt/wt%) (PHIM-f). The mechanisms of these results were proved by folate receptor mediated endocytosis of micelle and endosomal disruption function by it. In addition, the optical imaging demonstrated the future application of the diagnositic area. PHSM-f inhibited the growth of multidrug resistant ovarian tumors efficiently in mice, with minimum weight loss.
Conclusions
The pH-sensitive mixed micelle system demonstrates effective antitumor efficacy against the multidrug resistant ovarian tumor A2780/DOXR.
Similar content being viewed by others
Reference
L. Brannon-Peppas, and J. O. Blanchette. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56:1649–1659 (2004).
G. Szakacs, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe, and M. M. Gottesman. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5:219–234 (2006).
R. Duncan. Drug-polymer conjugates: potential for improved chemotherapy. Anticancer Drugs. 3:175–210 (1992).
V. P. Torchilin. Liposomes as targetable drug carriers. Crit. Rev. Ther. Drug Carr. Syst. 1:65–115 (1985).
M. Jones, and J. Leroux. Polymeric micelles—a new generation of colloidal drug carriers. Eur. J. Pharm. Biopharm. 48:101–111 (1999).
G. S. Kwon, and K. Kataoka. Block copolymer micelles as long circulating drug vehicles. Adv. Drug Deliv. Rev. 16:295–309 (1995).
S. V. Vinogradov, T. K. Bronich, and A. V. Kabanov. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv. Drug Deliv. Rev. 54:135–147 (2002).
H. Okada, and H. Toguchi. Biodegradable microspheres in drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 12:1–99 (1995).
G. P. Carino, J. S. Jacob, and E. Mathiowitz. Nanosphere based oral insulin delivery. J. Control. Release. 65:261–269 (2000).
H. Maeda. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41:189–207 (2001).
A. K. Larsen, A. E. Escargueil, and A. Skladanowski. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 88:217–229 (2000).
S. Bennis, C. Chapey, P. Couvreur, and J. Robert. Enhanced cytotoxicity of doxorubicin encapsulated in polyhexylcyanoacrylate nanospheres against multi-drug-resistant tumor cells in culture. Eur. J. Cancer A. 30:89–93 (1994).
S. Cammas, K. Suzuki, C. Sone, Y. Sakurai, K. Kataoka, and T. Okano. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J. Control. Release. 48:157–164 (1997).
J. E. Chung, M. Yokoyama, and T. Okano. Inner core segment design for drug delivery control of thermo-responsive polymeric micelles. J. Control. Release. 65:93–103 (2000).
J. Kopecek, P. Kopeckova, T. Minko, and Z. Lu. HPMA copolymer—anticancer drug conjugates: design, activity, and mechanism of action. Eur. J. Pharm. Biopharm. 50:61–81 (2000).
D. Putnam, and J. Kopecek. Enantioselective Release of 5-Fluorouracil from N-(2-Hydroxypropyl) methacrylamide-Based Copolymers via Lysosomal Enzymes. Bioconjug. Chem. 6:483–492 (1995).
E. S. Lee, K. Na, and Y. H. Bae. Polymeric micelle for tumor pH and folate-mediated targeting. J. Control. Release. 91:103–113 (2003).
E. S. Lee, K. Na, and Y. H. Bae. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J. Control. Release. 103:405–418 (2005).
E. S. Lee, K. Na, and Y. H. Bae. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 5:325–329 (2005).
E. R. Gillies, and J. M. Frechet. pH-responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug. Chem. 16:361–368 (2005).
D. C. Drummond, M. Zignani, and J. C. Leroux. Current status of pH-sensitive liposomes in drug delivery. Prog. Lipid Res. 39:409–460 (2000).
R. Duncan. Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway? Pharm. Sci. Technol. Today. 2:441–449 (1999).
E. R. Gillies, T. B. Jonsson, and J. M. Frechet. Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers. J. Am. Chem. Soc. 126:11936–11943 (2004).
R. Tomlinson, J. Heller, S. Brocchini, and R. Duncan. Polyacetal-doxorubicin conjugates designed for pH-dependent degradation. Bioconjug. Chem. 14:1096–1106 (2003).
M. Hruby, C. Konak, and K. Ulbrich. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release. 103:137–148 (2005).
Y. Bae, S. Fukushima, A. Harada, and K. Kataoka. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. Eng. 42:4640–4643 (2003).
S. D. Kong, A. Luong, G. Manorek, S. B. Howell, and J. Yang. Acidic hydrolysis of N-ethoxybenzylimidazoles (NEBIs): potential applications as pH-sensitive linkers for drug delivery. Bioconjug. Chem. 18:293–296 (2007).
S. M. Hahn, A. Russo, J. A. Cook, and J. B. Mitchell. A multidrug-resistant breast cancer line induced by weekly exposure to doxorubicin. Int. J. Oncol. 14:273–279 (1999).
H. Yin, E. S. Lee, D. Kim, K. H. Lee, K. T. Oh, and Y. H. Bae. Physicochemical characteristics of pH-sensitive poly(L-Histidine)-b-poly(ethylene glycol)/poly(L-Lactide)-b-poly(ethylene glycol) mixed micelles. J. Control. Release. 126:130–138 (2008).
E. S. Lee, H. J. Shin, K. Na, and Y. H. Bae. Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J. Control. Release. 90:363–374 (2003).
Z. G. Gao, H. D. Fain, and N. Rapport. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol. Pharmacol. 1:317–330 (2004).
K. Park, J. H. Kim, Y. S. Nam, S. Lee, H. Y. Nam, K. Kim, J. H. Park, I. S. Kim, K. Choi, S. Y. Kim, and I. C. Kwon. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J. Control. Release. 122:305–314 (2007).
Z. G. Gao, H. D. Fain, and N. Rapport. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J. Control. Release. 102:203–222 (2005).
E. C. Spoelstra, H. Dekker, G. J. Schuurhuis, H. J. Broxterman, and J. Lankelma. P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines: evidence for a saturation of active daunorubicin transport. Biochem. Pharmacol. 41:349–359 (1991).
Y. Lu, and P. S. Low. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. J. Control. Release. 91:17–29 (2003).
Y. Lu, and P. S. Low. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Deliv. Rev. 54:675–693 (2002).
G. Mohajer, E. S. Lee, and Y. H. Bae. Enhanced intracellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells. Pharm. Res. 24:1618–1627 (2007).
R. A. Jones, C. Y. Cheung, F. E. Black, J. K. Zia, P. S. Stayton, A. S. Hoffman, and M. R. Wilson. Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. Biochem. J. 372:65–75 (2003).
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, and M. J. Thun. Cancer statistics. CA Cancer J. Clin. 56:106–130 (2006).
S. A. Cannistra. Cancer of the ovary. N. Engl. J. Med. 351:2519–2529 (2004).
A. du Bois, M. Quinn, T. Thigpen, J. Vermorken, E. Avall-Lundqvist, M. Bookman, D. Bowtell, M. Brady, A. Casado, A. Cervantes, E. Eisenhauer, M. Friedlaender, K. Fujiwara, S. Grenman, J. P. Guastalla, P. Harper, T. Hogberg, S. Kaye, H. Kitchener, G. Kristensen, R. Mannel, W. Meier, B. Miller, J. P. Neijt, A. Oza, R. Ozols, M. Parmar, S. Pecorelli, J. Pfisterer, A. Poveda, D. Provencher, E. Pujade-Lauraine, M. Randall, J. Rochon, G. Rustin, S. Sagae, F. Stehman, G. Stuart, E. Trimble, P. Vasey, I. Vergote, R. Verheijen, and U. Wagner. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann. of Oncol. 16(Suppl. 8):viii7–viii12 (2005).
W. P. McGuire III. Current status of taxane and platinum-based chemotherapy in ovarian cancer. J. Clin. Oncol. 21(May 15 Suppl):133s–135s (2003).
J. L. Wike-Hooley, J. Haveman, and J. S. Reinhold. The relevance of tumor pH to the treatment of malignant disease. Radiother. Oncol. 2:343–366 (1984).
S. H. Jang, M. G. Wientjes, and J. L. Au. Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule. J. Pharmacol. Exp. Ther. 296:1035–1042 (2001).
S. H. Jang, M. G. Wientjes, D. Lu, and J. L. Au. Drug delivery and transport to solid tumors. Pharm. Res. 20:1337–1350 (2003).
A. Haidemenos, D. Kontis, A. Gazi, E. Kallai, M. Allin, and B. Lucia. Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 31:1289–1296 (2007).
Acknowledgment
This work was partially supported by NIH CA 101850. Drs. Zhonggao Gao, Kyung Taek Oh, and Han Chang Kang are acknowledged for their help with various experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, D., Lee, E.S., Park, K. et al. Doxorubicin Loaded pH-sensitive Micelle: Antitumoral Efficacy against Ovarian A2780/DOXR Tumor. Pharm Res 25, 2074–2082 (2008). https://doi.org/10.1007/s11095-008-9603-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9603-6